Sort
51,593 grants matching “hepatitis”
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes
$2,441,919Chad Albert Cowan · Massachusetts General Hospital · U01 · FY2014 · HL
Maternal and infant immunization to eliminate breast milk transmission of HIV-1
$2,440,281Sallie R. Permar · Duke University · P01 · FY2015 · AI
A binational cohort of the intersection between substance use, HIV, and associated comorbidities among people who inject drugs in San Diego, CA
$2,437,310Steffanie A Strathdee · University Of California, San Diego · U01 · FY2025 · DA
AIDS Linked to the IntraVenous Experience (ALIVE)
$2,437,098Shruti H Mehta · Johns Hopkins University · U01 · FY2023 · DA
AIDS Linked to the IntraVenous Experience (ALIVE)
$2,436,595Shruti H Mehta · Johns Hopkins University · U01 · FY2024 · DA
Case Clinical Trials Unit
$2,436,364Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2023 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,435,437Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2014 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,433,403Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2017 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,433,403Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2015 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,433,401Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2016 · AI
Reaching the hardest of the hard-to-reach
$2,430,000Sunil Suhas Solomon · Johns Hopkins University · DP2 · FY2016 · DA
General Clinical Research Center
$2,428,731Sheldon M Retchin · Virginia Commonwealth University · M01 · FY2009 · RR
Case Clinical Trials Unit
$2,428,514George Yendewa · Case Western Reserve University · UM1 · FY2025 · AI
Alcohol Associated Outcomes Among HIV+/- Aging Veterans
$2,428,227Amy Caroline Justice · Yale University · U10 · FY2009 · AA
Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos
$2,425,096Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2019 · HL
Biogenesis and Catabolism of Atherogenic Lipoproteins
$2,418,566M Mahmood Hussain · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2024 · HL
DETECTION AND MODELS OF TOXICANT EXPOSURE
$2,415,449Robert H Tukey · University Of California, San Diego · P42 · FY2019 · ES
DETECTION AND MODELS OF TOXICANT EXPOSURE
$2,415,449Robert H Tukey · University Of California, San Diego · P42 · FY2018 · ES
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$2,415,233Giorgio Trinchieri · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Structural Biology Of Virus Assembly
$2,411,527Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2010 · AR
Pharmacokinetics and Drug Metabolism
$2,410,920Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Triglycerides, Diabetes and Cardiovascular Disease
$2,409,622Karin E. Bornfeldt · University Of Washington · P01 · FY2020 · HL
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,408,617Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2023 · AG
The UCSD CD4 Collaborative Clinical Trial Unit
$2,407,704Constance Ann Benson · University Of California, San Diego · UM1 · FY2016 · AI
Biology of sex and cancer
$2,405,972Sarah Jackson · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA